[Edaily Reporter KYUNG GYEYOUNG ] DongKook Pharmaceutical Co.,Ltd. announced on the 24th that it has formed an advisory panel to begin full-scale development of “Madeca Labs,” a science-based dermocosmeceutical brand. The target launch date is the first half of 2027.

In this regard, DongKook Pharmaceutical Co.,Ltd. ( DongKook Pharmaceutical Co.,Ltd.(086450)) established an advisory panel last month consisting of five dermatologists, including Dr. Yoon Chun-sik, director of Yemiwon Dermatology Clinic. Based on research into “Centella Asiatica Quantified Extract” (TECA)—DongKook Pharmaceutical Co.,Ltd.’s key ingredient derived from gotu kola—the advisory panel discussed mechanisms of action on the skin and directions for formulation development. They plan to actively participate in the development process, including decisions on key ingredients, full ingredient lists, and user experience, through regular meetings.

DongKook Pharmaceutical Co.,Ltd. plans to launch a high-performance skincare brand for use in clinics and hospitals, leveraging the company’s unique R&D capabilities and advice from dermatologists. Madeca Labs aims to address a wide range of skin concerns, including the skin barrier, sensitive skin, post-procedure home care, and skin condition management.

A representative from DongKook Pharmaceutical Co.,Ltd.’s Dermacosmeceutical Team stated, “Madeca Labs is a high-performance skincare brand developed in collaboration with dermatologists based on medical and scientific evidence,” adding, “Leveraging DongKook Pharmaceutical Co.,Ltd.’s accumulated Madeca heritage, dermatological research capabilities, and the expertise of dermatologists, we will introduce trustworthy skincare solutions through specialized hospital and clinic channels.”

Previously, DongKook Pharmaceutical Co.,Ltd. launched the dermocosmetic brand “Centellian24” in 2015 and has since been expanding the lineup of its clinic-exclusive brand “Madeca MD.” With the launch of Madeca Labs next year, the company plans to gradually expand its dermocosmeceutical business, focusing on clinics and medical institutions.